摘要
目的:探讨痰热清注射液配合常规疗法治疗慢性阻塞性肺疾病(COPD)急性发作的疗效及其可能的作用机制。方法:102例COPD急性发作期患者随机分为常规疗法组和联用痰热清治疗组;联用痰热清治疗组在常规疗法的基础上联用痰热清注射液治疗。观察两组临床疗效、症状积分及血气分析结果。结果:联用痰热清治疗组显效率为72.55%,常规疗法组为58.82%,差异有显著性(P<0.05)。治疗后联用痰热清治疗组患者症状积分及血气分析结果均明显优于常规组(P<0.05)。结论:在常规疗法的基础上联用痰热清注射液治疗COPD急性发作能明显提高临床疗效,这可能与痰热清注射液对多种病原菌均有较好的抑制作用,减少内毒素产生,进而减轻COPD的炎症过程有关。
Objective： To observe the effects of treatment with Tanreqing injections combined with routine methods in acute COPD and study the mechanism of action. Methods： 102 patients with COPD were divided into two groups randomly. In the combined group, we added Tanreqing injections in the treatment.We observed the effects of treatment and symptom integral and blood gas analysis of patients. Results： The combined group＇s effective rate was 72.55%, routine methods group was 58.82%. Difference was apparent （P〈0.05）. The levels of symptom integral and blood gas analysis in combined group was significantly excel than routine group （P〈0.05）after treatment. Conclusion： On the basis of routine treatment combined with Tanreqing injections can heighten the curative effect in COPD. It＇s concern with that Tanreqing could depressed markedly multitude of pathogenic bacterium, lighten production of cndotoxin and lessen inflammation of COPD.
出处
《中国医药导报》
CAS
2009年第1期88-89,共2页
China Medical Herald
